• Swedencare is expanding Vetio’s US manufacturing footprint with a 100,000-square-foot addition for OTC and Rx topical products.
• New production capacity is also being added for injection-molded treats as Vetio scales its global animal health CDMO operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Swedencare AB published the original content used to generate this news brief on July 30, 2026, and is solely responsible for the information contained therein.